These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 35953251

  • 21. Measles, mumps, rubella prevention: how can we do better?
    Kauffmann F, Heffernan C, Meurice F, Ota MOC, Vetter V, Casabona G.
    Expert Rev Vaccines; 2021 Jul; 20(7):811-826. PubMed ID: 34096442
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Coverage survey of Measles-Rubella mass vaccination campaign in a rural area in Tamil Nadu.
    Priyadharshini, Jasmine A.
    J Family Med Prim Care; 2019 Jun; 8(6):1884-1888. PubMed ID: 31334150
    [Abstract] [Full Text] [Related]

  • 25. Congenital Rubella Syndrome Surveillance After Measles Rubella Vaccination Introduction in Yogyakarta, Indonesia.
    Herini ES, Triono A, Iskandar K, Prasetyo A, Nugrahanto AP, Gunadi.
    Pediatr Infect Dis J; 2021 Dec 01; 40(12):1144-1150. PubMed ID: 34609101
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Increased measles-mumps-rubella (MMR) vaccine uptake in the context of a targeted immunisation campaign during a measles outbreak in a vaccine-reluctant community in England.
    Le Menach A, Boxall N, Amirthalingam G, Maddock L, Balasegaram S, Mindlin M.
    Vaccine; 2014 Feb 26; 32(10):1147-52. PubMed ID: 24440207
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Examining enablers of vaccine hesitancy toward routine childhood and adolescent vaccination in Malawi.
    Adeyanju GC, Betsch C, Adamu AA, Gumbi KS, Head MG, Aplogan A, Tall H, Essoh TA.
    Glob Health Res Policy; 2022 Aug 18; 7(1):28. PubMed ID: 35978401
    [Abstract] [Full Text] [Related]

  • 34. Measles and rubella vaccination coverage in Haiti, 2012: progress towards verifying and challenges to maintaining measles and rubella elimination.
    Tohme RA, François J, Wannemuehler K, Magloire R, Danovaro-Holliday MC, Flannery B, Cavallaro KF, Fitter DL, Purcell N, Dismer A, Tappero JW, Vertefeuille JF, Hyde TB.
    Trop Med Int Health; 2014 Sep 18; 19(9):1105-15. PubMed ID: 25041586
    [Abstract] [Full Text] [Related]

  • 35. Measles and rubella serosurvey identifies rubella immunity gap in young adults of childbearing age in Zambia: The added value of nesting a serological survey within a post-campaign coverage evaluation survey.
    Hayford K, Mutembo S, Carcelen A, Matakala HK, Munachoonga P, Winter A, Wanyiri JW, Searle K, Mwansa FD, Mwiche A, Phiri C, Book C, Thuma PE, Moss WJ.
    Vaccine; 2019 Apr 17; 37(17):2387-2393. PubMed ID: 30905529
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Measles-rubella mass immunization campaign in Albania, November 2000.
    Bino S, Kakarriqi E, Xibinaku M, Ion-Nedelcu N, Bukli M, Emiroglu N, Uzicanin A.
    J Infect Dis; 2003 May 15; 187 Suppl 1():S223-9. PubMed ID: 12721917
    [Abstract] [Full Text] [Related]

  • 40. Economic analysis of measles elimination program in the Republic of Korea, 2001: a cost benefit analysis study.
    Bae GR, Choe YJ, Go UY, Kim YI, Lee JK.
    Vaccine; 2013 May 31; 31(24):2661-6. PubMed ID: 23602654
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.